Receptor Protein-Tyrosine Kinases, antagonists & inhibitors

All categories
DBCAT001758Pharmacologic class

A DrugBank category of 4 drugs. 2 of them are approved.

Also known as
Receptor Tyrosine Kinase Inhibitor
Drugs

What you can answer from here — as of May 14, 2018

4DrugsEach linked to its full drug card
Listed above
18Drug targetsEvery drug–target pair in the class, with bond type
Sign in
59Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Receptor Protein-Tyrosine Kinases, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In